Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 521 of 6351
-
New hope for rare cancer: virus-based therapy combined with immunotherapy
Disease control Recruiting nowThis is a multicenter, open-label study of Intratumoral Vusolimogene Oderparepvec (VO) to investigate safety and estimate when used in combination with pembrolizumab for treating participants with angiosarcoma. This is the first study evaluating this novel combination in particip…
Phase 2 • Sponsor: Varun Monga, MBBS • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Gene therapy trial aims to halt vision loss in dry AMD
Disease control Recruiting nowThis is a Phase 1/2 study, multi-center, dose-escalation interventional study of BS01 in subjects with GA secondary to dry AMD. Part 1 is an open label dose-escalation study; Part 2 is a dose-expansion study with dose(s) selected from Part 1 based on a benefit/risk assessment, an…
Phase 1/2 • Sponsor: Bionic Sight LLC • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a ketamine nasal spray quickly ease severe depression in suicidal teens?
Symptom relief Recruiting nowThe purpose of this study is to evaluate how well JNJ-54135419 works (efficacy) in addition to comprehensive standard of care (SoC) in rapidly reducing the symptoms of major depressive disorder (MDD, a mental disorder characterized by a persistent feeling of sadness and loss of i…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control Recruiting nowThis is a Ph 2, randomized, double-blind, placebo-controlled global multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of PIPE-791 in participants with a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) with or without background treatment…
Phase 2 • Sponsor: Contineum Therapeutics • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New combo drug aims to help teens shed excess weight
Disease control Recruiting nowThis study will look at how well CagriSema and cagrilintide help children and adolescents with excess body weight lose weight. The study has 2 parts: main and extension study. In the main study, participants will either get CagriSema (a new study drug), cagrilintide (a new study …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New combo therapy takes on tough pancreatic cancer
Disease control Recruiting nowThis study is a randomized, open-label, multicenter Phase II clinical trial designed to evaluate the Safety, Tolerability and Preliminary Efficacy of HRS-4642 Combination with Other Antitumor Therapies in Patients with Solid Tumors
Phase 1/2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for myeloma patients who Can't have transplants
Disease control Recruiting nowMultiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures, infections, weaker bones, and kidney failure. This is a study to determine the adv…
Phase 2/3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New cancer drug shows promise for Hard-to-Treat tumors and brain spread
Disease control Recruiting nowThis study is a multicenter, open-label study designed to evaluate SPR1020 in adult patients with advanced solid tumors. The study aims to characterize the safety, tolerability, pharmacokinetic (PK) profile, and preliminary antitumor activity of SPR1020 monotherapy in this popula…
Phase 1/2 • Sponsor: Shanghai SciBrunch Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo therapy aims to stop rare organ disease
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of SCTC21C plus cyclophosphamide, bortezomib and dexamethasone (VCd) compared with VCd alone in treatment of newly diagnosed amyloid light chain (AL) amyloidosis participants.
Phase 3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can a dissolvable dressing get burn patients to skin grafts faster?
Disease control Recruiting nowThis is a prospective, randomized, controlled, multi-center clinical study comparing SupraSDRM® to standard of care wound dressing, BTM, in the treatment of full-thickness wounds deemed not immediately suitable for definitive grafting will be performed.
Sponsor: The Metis Foundation • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
One scan, many answers: can a new CT predict heart risks after stenting?
Diagnosis Recruiting nowThis study takes patients who have undergone percutaneous coronary intervention as the research subjects and employs a prospective observational cohort design, aiming to develop and validate a "one-stop" photon-counting computed tomography imaging framework. The one-stop PCCT pro…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Can a new CT scanner see carotid plaques better?
Diagnosis Recruiting nowThis prospective observational study aims to compare photon-counting detector computed tomography angiography (PCD-CTA) with conventional energy-integrating detector computed tomography angiography (EID-CTA) for the assessment of carotid atherosclerotic plaques in patients with c…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
New device aims to clear leg artery clots without major surgery
Disease control Recruiting nowThis study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
Sponsor: Inari Medical • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New blood test could revolutionize breast cancer screening
Diagnosis Recruiting nowBreast cancer is the most common cancer that spreads beyond the initial layer of tissue it developed in, and grows into surrounding healthy tissue in women worldwide. It is associated with significant illness and death. Identifying the disease in the early stage is important to a…
Sponsor: Syantra Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New triple therapy aims to deepen remission in untreated CLL
Disease control Recruiting nowThis phase II trial tests the effect of venetoclax and obinutuzumab followed by epcoritamab in treating patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that have not previously received treatment. Venetoclax is in a class of medications called…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control Recruiting nowThe purpose of this study is to determine whether combining Loncastuximab Tesirine with Epcoritamab is tolerable and effective for reducing and/or eliminating lymphoma cells in the body.
Phase 2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New precision surgery aims to save more rectal cancer Patients' bowel function
Disease control Recruiting nowThis comparative study evaluates the short- and long-term outcomes of Quadrant-based Intersphincteric Resection (Q-ISR) versus traditional subtotal ISR (Sub-ISR) and conventional/total ISR (t-ISR) in patients with ultra-low rectal cancer undergoing sphincter-preserving surgery, w…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
A sharper CT scan could replace invasive stent checks
Diagnosis Recruiting nowIntracranial atherosclerotic disease is an important cause of ischemic stroke, and intracranial stent implantation is increasingly used for patients with severe stenotic lesions. Evaluation of stent patency and detection of in-stent restenosis are essential during follow-up. Digi…
Sponsor: Xin Lou • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
New drug cocktail aims to tame stubborn IBD
Disease control Recruiting nowPatients with refractory inflammatory bowel disease (IBD) show inadequate response to conventional biologics and small molecule drugs, with persistently active disease that severely impacts quality of life and long-term prognosis. Current treatment options are limited, and the su…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Virtual city simulator trains blind individuals to dodge Real-World hazards
Disease control CompletedThis study evaluates a novel digital twin smart educational platform designed to train visually impaired individuals on safe navigation in Saudi urban environments. Independent mobility is challenging for visually impaired people due to dynamic hazards and architectural changes. …
Sponsor: King Salman Center for Disability Research • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC